Xarelto in the Prophylaxis of Post Surgical Venous Thromboembolism After Elective Major Orthopedic Surgery of Hip or Knee.
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Rivaroxaban (Primary) ; Antithrombotics
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Adverse reactions
- Acronyms XAMOS
- Sponsors Bayer
- 18 Nov 2015 Results assessing co-medication interactions published in the British Journal of Clinical Pharmacology (n = 17701).
- 11 Apr 2013 Planned end date changed from 1 Mar 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.